US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Palisade Bio Inc.

0.7200

-0.0155-2.11%

Post-market: 0.76000.0400+5.56%19:09 EDT

Volume:24.24K

Turnover:17.46K

Market Cap:3.17M

PE:-0.07

High:0.7775

Open:0.7300

Low:0.6900

Close:0.7355

Loading ...

Overview Company News Filings

Palisade completes dosing in Phase 1b portion of Phase 1a/1n study of PALI-2108

BRIEF-Palisade Bio Completes Dosing In Phase 1A Portion Of Ongoing Phase 1A/B Study Of Pali-2108

Palisade Bio Inc - to Report Topline Data From Phase 1a Study by End of May 2025

THOMSON REUTERS

Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108

U.S. RESEARCH ROUNDUP-Ashland, Connectone Bancorp, Neurocrine Biosciences

Palisade Bio Inc expected to post a loss of $1.99 a share - Earnings Preview

Palisade Bio Begins Dosing Ulcerative Colitis Patients in PALI-2108 Trial

MT Newswires Live

Palisade Bio: No Serious Adverse Events & No Treatment-Emergent Adverse Events Related to Laboratory Values or Ekgs Seen to Date

THOMSON REUTERS

Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/B Study of Pali-2108

THOMSON REUTERS

Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108

Palisade Bio Participates in Virtual Investor “What This Means” Segment

Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis

Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress

Palisade Bio to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar

Palisade Bio Completes All Five Sad Cohorts and Advances to Mad Cohorts of Phase 1a/B Study of Pali-2108 for Treatment of Ulcerative Colitis

THOMSON REUTERS

Palisade Bio Completes All Five SAD Cohorts and Advances to MAD Cohorts of Phase 1a/b Study of PALI-2108 for Treatment of Ulcerative Colitis

BRIEF-Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Palisade Bio appoints Feagan to Clinical Advisory Board

Palisade Bio Appoints Brian Feagan, Md, Frcpc, to Its Clinical Advisory Board

THOMSON REUTERS

Palisade Bio Announces Pricing of $5 Million Underwritten Public Offering Priced at-Market Under Nasdaq Rules

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PALI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PALI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PALI\",,,,,undefined,":{"symbol":"PALI","market":"US","secType":"STK","nameCN":"Palisade Bio Inc.","latestPrice":0.72,"timestamp":1745611200000,"preClose":0.7355,"halted":0,"volume":24237,"hourTrading":{"tag":"盘后","latestPrice":0.76,"preClose":0.72,"latestTime":"19:09 EDT","volume":641,"amount":485.921,"timestamp":1745622587616},"delay":0,"floatShares":4089271,"shares":4396646,"eps":-10.192937,"marketStatus":"Market Closed","change":-0.0155,"latestTime":"04-25 16:00:00 EDT","open":0.73,"high":0.7775,"low":0.69,"amount":17462.007153000002,"amplitude":0.118967,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.192937,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"listingDate":1188187200000,"exchange":"NASDAQ","adjPreClose":0.7355,"preHourTrading":{"tag":"盘前","latestPrice":0.7501,"preClose":0.7355,"latestTime":"08:51 EDT","volume":12,"amount":9.000100080000001,"timestamp":1745585482879},"postHourTrading":{"tag":"盘后","latestPrice":0.76,"preClose":0.72,"latestTime":"19:09 EDT","volume":641,"amount":485.921,"timestamp":1745622587616},"volumeRatio":0.719544706523881},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PALI\",,,,,undefined,":{"symbol":"PALI","floatShares":4089271,"roa":"-74.50%","roe":"-153.55%","lyrEps":-10.192937,"volumeRatio":0.719544706523881,"shares":4396646,"dividePrice":0,"high":0.7775,"amplitude":0.118967,"preClose":0.7355,"low":0.69,"week52Low":0.6,"pbRate":"0.42","week52High":9.09,"institutionHeld":-0.0144,"latestPrice":0.72,"eps":-10.192937,"divideRate":0,"volume":24237,"delay":0,"ttmEps":-10.192937,"open":0.73,"prevYearClose":1.65,"prevWeekClose":0.7199,"prevMonthClose":0.6808,"prevQuarterClose":0.6808,"fiveDayClose":0.7199,"twentyDayClose":0.6895,"sixtyDayClose":1.43},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PALI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526366631","title":"Palisade completes dosing in Phase 1b portion of Phase 1a/1n study of PALI-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2526366631","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526366631?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:36","pubTimestamp":1744202180,"startTime":"0","endTime":"0","summary":"Palisade Bio (PALI) announced the completion of enrollment and dosing in all five Phase 1a SAD cohorts, all four MAD cohorts, and the food effects ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palisade-completes-dosing-in-phase-1b-portion-of-phase-1a-1n-study-of-pali-2108?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palisade-completes-dosing-in-phase-1b-portion-of-phase-1a-1n-study-of-pali-2108?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2526736500","title":"BRIEF-Palisade Bio Completes Dosing In Phase 1A Portion Of Ongoing Phase 1A/B Study Of Pali-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2526736500","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526736500?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:35","pubTimestamp":1744202143,"startTime":"0","endTime":"0","summary":"BRIEF-Palisade Bio Completes Dosing In Phase 1A Portion Of Ongoing Phase 1A/B Study Of Pali-2108April 9 (Reuters) - Palisade Bio Inc PALI.O:PALISADE BIO COMPLETES DOSING IN PHASE 1A PORTION OF ONGOING","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN0W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PALI","BK4007"],"gpt_icon":0},{"id":"2526365789","title":"Palisade Bio Inc - to Report Topline Data From Phase 1a Study by End of May 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2526365789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526365789?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:30","pubTimestamp":1744201817,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QN0W7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PALI","BK4139","BK4007"],"gpt_icon":0},{"id":"2526366885","title":"Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2526366885","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526366885?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:30","pubTimestamp":1744201800,"startTime":"0","endTime":"0","summary":"Sustained positive preliminary data from all completed single ascending dose (SAD) cohorts, multiple ascending dose (MAD) cohorts, and food effects crossover, further supporting the safety and tolerab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/09/3058394/0/en/Palisade-Bio-Completes-Dosing-in-Phase-1a-Portion-of-Ongoing-Phase-1a-b-Study-of-PALI-2108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","ALC","BK4007","BK4139","BK4198","LU1804176565.USD","LU2265009873.SGD","PALI"],"gpt_icon":0},{"id":"2522617819","title":"U.S. RESEARCH ROUNDUP-Ashland, Connectone Bancorp, Neurocrine Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2522617819","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522617819?lang=en_us&edition=fundamental","pubTime":"2025-03-26 15:46","pubTimestamp":1742975171,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Ashland, Connectone Bancorp, Neurocrine Biosciences March 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL3N3Q90KA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LAKE","LU2229751404.USD","CRMD","COTY","CNOB","LU0053671581.USD","BK4183","IE00B19Z3B42.SGD","LU2087625088.SGD","LU2125910336.SGD","BK4585","WLK","IE00B19Z4B17.USD","BK4200","BK4590","IE00B19Z3581.USD","BK4516","SUN","IE0002270589.USD","ASH","NBIX","LU0889565916.HKD","PZZA","LU0353189680.USD","RUM","IE00B7SZL793.SGD","LU2089279066.USD","CNM","BK4539","BK4139","LU2125910179.SGD","ULTA","BK4211","PALI","FRPT","LU0266013472.USD","LU2065170008.USD","LU2065171311.SGD","LU2065171402.SGD","LU0823416689.USD","IE0031619046.USD","LU2463526074.USD","CRNX","BK4090","BK4104","LU0029874061.USD","KBH","LU0823411888.USD","BK4077"],"gpt_icon":0},{"id":"2521289492","title":"Palisade Bio Inc  expected to post a loss of $1.99 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521289492","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521289492?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:03","pubTimestamp":1742562198,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc  expected to post a loss of $1.99 a share - Earnings Preview Palisade Bio Inc PALI.OQ PALI.O is expected to show no change in quarterly revenue when it reports  results on March 25 (e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q415K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI"],"gpt_icon":1},{"id":"2519730809","title":"Palisade Bio Begins Dosing Ulcerative Colitis Patients in PALI-2108 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2519730809","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519730809?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:57","pubTimestamp":1741957023,"startTime":"0","endTime":"0","summary":"Palisade Bio  said Friday it began dosing ulcerative colitis patients in the final cohort of its phase 1a/b study of PALI-2108.The company said it had completed five single ascending dose cohorts and three of four multiple ascending dose cohorts, with no serious adverse events or treatment-related adverse events tied to lab results or EKGs.Palisade Bio said it plans to report topline data in H1.Shares of the company were up 3% in recent Friday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PALI","BK4139","BK4007"],"gpt_icon":1},{"id":"2519806520","title":"Palisade Bio: No Serious Adverse Events & No Treatment-Emergent Adverse Events Related to Laboratory Values or Ekgs Seen to Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2519806520","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519806520?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:30","pubTimestamp":1741955431,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nFWN3PX0PM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","PALI"],"gpt_icon":0},{"id":"2519065378","title":"Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/B Study of Pali-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2519065378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519065378?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:30","pubTimestamp":1741955431,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nFWN3PX0PM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"2519061888","title":"Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108","url":"https://stock-news.laohu8.com/highlight/detail?id=2519061888","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519061888?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:30","pubTimestamp":1741955400,"startTime":"0","endTime":"0","summary":"Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts support safety and tolerability of PALI-2108 No serious adve","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/14/3042967/0/en/Palisade-Bio-Commences-Dosing-in-First-Ulcerative-Colitis-Patient-Cohort-in-Ongoing-Phase-1a-b-Study-of-PALI-2108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4534","ALC","PALI","LU2265009873.SGD","BK4198","LU1804176565.USD","BK4007"],"gpt_icon":0},{"id":"2516679792","title":"Palisade Bio Participates in Virtual Investor “What This Means” Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2516679792","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516679792?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:30","pubTimestamp":1741095000,"startTime":"0","endTime":"0","summary":"Dr. Joerg Heyer, Head of Translational Science and Medicine of Palisade Bio highlights preclinical data for lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis . Carlsbad, CA, March 04, 2025  -- Palisade Bio, Inc.  , a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced the release of a Virtual Investor “What This Means” segment.As part of this segment, Dr. Heyer discussed the Company’s positive preclinical data for its lead product candidate, PALI-2108, which was recently presented at the 2025 Crohn’s and Colitis Congress and what this means for Palisade’s UC development program.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/palisade-bio-participates-virtual-investor-133000559.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","PALI","BK4139"],"gpt_icon":0},{"id":"2510571238","title":"Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2510571238","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510571238?lang=en_us&edition=fundamental","pubTime":"2025-02-10 21:45","pubTimestamp":1739195100,"startTime":"0","endTime":"0","summary":"Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure  Company","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/10/3023457/0/en/Palisade-Bio-Presents-Positive-Preclinical-Data-of-PALI-2108-for-the-Treatment-of-Ulcerative-Colitis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","BK4139","PALI","BK4007","BK4181","PK"],"gpt_icon":1},{"id":"2507636905","title":"Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2507636905","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507636905?lang=en_us&edition=fundamental","pubTime":"2025-01-29 21:45","pubTimestamp":1738158300,"startTime":"0","endTime":"0","summary":"Carlsbad,CA, Jan. 29, 2025  -- Palisade Bio, Inc. , a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that its abstract has been accepted for poster presentation at the Crohn’s & Colitis Congress being held February 6-8, 2025 in San Francisco, CA.Details of the poster presentation are as follows:. Session: Poster and Exhibition Hall ReceptionPoster Title: PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS Mouse Model Session Dates and Times: February 7, 2025 from 5:00 PM to 6:30 PM PSTPresentation Location: Level 1 – Exhibition Hall – Moscone West","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/palisade-bio-selected-poster-presentation-134500430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PALI","BK4007"],"gpt_icon":0},{"id":"2505744710","title":"Palisade Bio to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2505744710","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505744710?lang=en_us&edition=fundamental","pubTime":"2025-01-22 21:00","pubTimestamp":1737550800,"startTime":"0","endTime":"0","summary":"Live webcast on Wednesday, January 29th at 2:20 PM ET. Carlsbad,CA, Jan. 22, 2025  -- Palisade Bio, Inc.  , a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that JD Finley, Chief Executive Officer of Palisade will present at LIVE!with Webull Corporate Connect: Healthcare Investment Webinar being held on January 29, 2025.Date/Time: Wednesday, January 29, 2025 at 2:20 PM ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/palisade-bio-present-live-webull-130000769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4137","BK4007","SIPC","PALI","HCSG","BK4139"],"gpt_icon":0},{"id":"2503999969","title":"Palisade Bio Completes All Five Sad Cohorts and Advances to Mad Cohorts of Phase 1a/B Study of Pali-2108 for Treatment of Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2503999969","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503999969?lang=en_us&edition=fundamental","pubTime":"2025-01-16 21:02","pubTimestamp":1737032563,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250116:nFWN3OC0NF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"2503434999","title":"Palisade Bio Completes All Five SAD Cohorts and Advances to MAD Cohorts of Phase 1a/b Study of PALI-2108 for Treatment of Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2503434999","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503434999?lang=en_us&edition=fundamental","pubTime":"2025-01-16 21:00","pubTimestamp":1737032400,"startTime":"0","endTime":"0","summary":"Company on track to report topline data in first half of 2025 Positive preliminary data from all five single ascending dose (SAD) cohorts ranging from 15mg to 450mg support safety and tolerability of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/16/3010756/0/en/Palisade-Bio-Completes-All-Five-SAD-Cohorts-and-Advances-to-MAD-Cohorts-of-Phase-1a-b-Study-of-PALI-2108-for-Treatment-of-Ulcerative-Colitis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALC","LU2265009873.SGD","LU1804176565.USD","BK4139","BK4218","BK4198","BK4007","PK","BK4534","BK4181","PALI"],"gpt_icon":1},{"id":"2500178303","title":"BRIEF-Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500178303","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500178303?lang=en_us&edition=fundamental","pubTime":"2025-01-04 07:00","pubTimestamp":1735945259,"startTime":"0","endTime":"0","summary":"BRIEF-Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)Palisade Bio Inc PALI.O:PALISADE BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nGNX6t54Q4Further company coverage: PALI.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250103:nTUA8SY3ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2492950333","title":"Palisade Bio appoints Feagan to Clinical Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2492950333","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492950333?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:47","pubTimestamp":1734443233,"startTime":"0","endTime":"0","summary":"Palisade Bio (PALI) announced the appointment of Brian Feagan, MD, FRCPC, to its Clinical Advisory Board. Published first on TheFly – the ultimate ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palisade-bio-appoints-feagan-to-clinical-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palisade-bio-appoints-feagan-to-clinical-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PALI","BK4007"],"gpt_icon":0},{"id":"2492952257","title":"Palisade Bio Appoints Brian Feagan, Md, Frcpc, to Its Clinical Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2492952257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492952257?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:30","pubTimestamp":1734442201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUA6JY6RD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2491033198","title":"Palisade Bio Announces Pricing of $5 Million Underwritten Public Offering Priced at-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2491033198","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491033198?lang=en_us&edition=fundamental","pubTime":"2024-12-13 01:05","pubTimestamp":1734023100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA9GJ7JZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","PALI","BK4585","LU2210149790.SGD","IE00B64PRP62.GBP","BK4588","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","NDAQ","BK4007","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PALI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-24","symbol":"PALI","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":-0.69},{"market":"US","date":"2024-11-12","symbol":"PALI","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-2.32},{"date":"2024-08-13","symbol":"PALI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723536000000,"name":null,"time":"Pre-Market","dateTimestamp":1723521600000,"actualEps":null},{"date":"2024-05-14","symbol":"PALI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715673600000,"name":null,"time":"Pre-Market","dateTimestamp":1715659200000,"actualEps":null},{"market":"US","date":"2024-04-08","symbol":"PALI","defaultRemindTime":1712583000000,"type":"split","dateTimestamp":1712548800000,"forFactor":15,"toFactor":1,"ratio":15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PALI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PALI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1732161600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PALI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PALI","date":"2025-04-25","current":-0.223974,"percent":0.836649,"low":-8.398968,"twenty":-0.843194,"median":-0.411077,"eighty":-0.265745,"high":5.714804,"avg":-0.457114,"sd":1.318947,"marketCap":3233733},"quantilePoints":[{"date":"2021-04-30","current":-6.235722,"twenty":-7.595945,"median":-6.39141,"eighty":-6.297997,"marketCap":55734879},{"date":"2021-05-07","current":-4.877259,"twenty":-6.329135,"median":-5.199166,"eighty":-4.928997,"marketCap":43592940},{"date":"2021-05-14","current":-3.071774,"twenty":-5.894847,"median":-4.877259,"eighty":-4.31519,"marketCap":27455520},{"date":"2021-05-21","current":-3.088114,"twenty":-5.23604,"median":-4.366658,"eighty":-3.120792,"marketCap":27601560},{"date":"2021-05-28","current":-3.112623,"twenty":-5.01152,"median":-3.758022,"eighty":-3.016221,"marketCap":27820620},{"date":"2021-06-04","current":-3.088114,"twenty":-4.980735,"median":-3.235167,"eighty":-3.058703,"marketCap":27601560},{"date":"2021-06-11","current":-3.357711,"twenty":-4.834777,"median":-3.235167,"eighty":-3.075042,"marketCap":30011220},{"date":"2021-06-18","current":-3.37405,"twenty":-4.607662,"median":-3.316863,"eighty":-3.088114,"marketCap":30157260},{"date":"2021-06-25","current":-3.58646,"twenty":-4.374011,"median":-3.345457,"eighty":-3.091382,"marketCap":32055780},{"date":"2021-07-02","current":-2.965569,"twenty":-4.341333,"median":-3.341372,"eighty":-3.091382,"marketCap":26506260},{"date":"2021-07-09","current":-3.096283,"twenty":-4.289047,"median":-3.316863,"eighty":-3.071774,"marketCap":27674580},{"date":"2021-07-16","current":-2.056128,"twenty":-3.758022,"median":-3.239251,"eighty":-2.990078,"marketCap":24607740},{"date":"2021-07-23","current":-2.074432,"twenty":-3.59463,"median":-3.210658,"eighty":-2.883873,"marketCap":24826800},{"date":"2021-07-30","current":-1.787672,"twenty":-3.58646,"median":-3.198403,"eighty":-2.373394,"marketCap":21394860},{"date":"2021-08-06","current":-1.647343,"twenty":-3.553782,"median":-3.112623,"eighty":-2.123242,"marketCap":19715400},{"date":"2021-08-13","current":-1.58633,"twenty":-3.463916,"median":-3.092199,"eighty":-2.074432,"marketCap":18985200},{"date":"2021-08-20","current":-1.549723,"twenty":-3.447577,"median":-3.071774,"eighty":-1.928001,"marketCap":18547080},{"date":"2021-08-27","current":-0.68888,"twenty":-3.431237,"median":-2.990078,"eighty":-1.683951,"marketCap":28838584},{"date":"2021-09-03","current":-0.743337,"twenty":-3.431237,"median":-2.965569,"eighty":-1.659545,"marketCap":31118314},{"date":"2021-09-10","current":-0.816854,"twenty":-3.392023,"median":-2.932891,"eighty":-1.582669,"marketCap":34195950},{"date":"2021-09-17","current":-0.74606,"twenty":-3.375684,"median":-2.859364,"eighty":-1.503353,"marketCap":31232301},{"date":"2021-09-24","current":-0.658929,"twenty":-3.360979,"median":-2.373394,"eighty":-0.786902,"marketCap":27584733},{"date":"2021-10-01","current":-0.677989,"twenty":-3.351175,"median":-2.205609,"eighty":-0.760763,"marketCap":28382638},{"date":"2021-10-08","current":-0.756712,"twenty":-3.343006,"median":-2.123242,"eighty":-0.751505,"marketCap":31678255},{"date":"2021-10-15","current":-0.85246,"twenty":-3.3283,"median":-2.086634,"eighty":-0.753683,"marketCap":35686524},{"date":"2021-10-22","current":-0.80613,"twenty":-3.318497,"median":-2.056128,"eighty":-0.756215,"marketCap":33747039},{"date":"2021-10-29","current":-0.846283,"twenty":-3.303792,"median":-1.860887,"eighty":-0.76126,"marketCap":35427926},{"date":"2021-11-05","current":-0.880257,"twenty":-3.254774,"median":-1.683951,"eighty":-0.762791,"marketCap":36850215},{"date":"2021-11-12","current":-1.134957,"twenty":-3.236801,"median":-1.674799,"eighty":-0.764674,"marketCap":36242580},{"date":"2021-11-19","current":-1.045691,"twenty":-3.235167,"median":-1.659545,"eighty":-0.782546,"marketCap":33392040},{"date":"2021-11-26","current":-0.981929,"twenty":-3.220462,"median":-1.604634,"eighty":-0.786902,"marketCap":31355940},{"date":"2021-12-03","current":-0.786393,"twenty":-3.210658,"median":-1.558874,"eighty":-0.786902,"marketCap":25111900},{"date":"2021-12-10","current":-0.892663,"twenty":-3.210658,"median":-1.507014,"eighty":-0.786902,"marketCap":28505400},{"date":"2021-12-17","current":-0.807647,"twenty":-3.195953,"median":-1.139207,"eighty":-0.786902,"marketCap":25790600},{"date":"2021-12-23","current":-0.709879,"twenty":-3.179613,"median":-1.06907,"eighty":-0.786393,"marketCap":22668580},{"date":"2021-12-31","current":-0.552601,"twenty":-3.146935,"median":-0.994681,"eighty":-0.758986,"marketCap":17646200},{"date":"2022-01-07","current":-0.565353,"twenty":-3.109355,"median":-0.984055,"eighty":-0.751505,"marketCap":18053420},{"date":"2022-01-14","current":-0.552601,"twenty":-3.101185,"median":-0.973427,"eighty":-0.743337,"marketCap":17646200},{"date":"2022-01-21","current":-0.448457,"twenty":-3.094649,"median":-0.914232,"eighty":-0.729723,"marketCap":14320570},{"date":"2022-01-28","current":-0.467585,"twenty":-3.088114,"median":-0.892637,"eighty":-0.708328,"marketCap":14931400},{"date":"2022-02-04","current":-0.393367,"twenty":-3.084846,"median":-0.884161,"eighty":-0.689425,"marketCap":12561379},{"date":"2022-02-11","current":-0.429328,"twenty":-3.068506,"median":-0.872535,"eighty":-0.671031,"marketCap":13709740},{"date":"2022-02-18","current":-0.403016,"twenty":-3.042364,"median":-0.855548,"eighty":-0.659474,"marketCap":12869509},{"date":"2022-02-25","current":-0.391071,"twenty":-2.990078,"median":-0.850155,"eighty":-0.641867,"marketCap":12488080},{"date":"2022-03-04","current":-0.393154,"twenty":-2.990078,"median":-0.849371,"eighty":-0.599359,"marketCap":12554592},{"date":"2022-03-11","current":-0.442081,"twenty":-2.990078,"median":-0.849371,"eighty":-0.582356,"marketCap":14116960},{"date":"2022-03-18","current":-0.602849,"twenty":-2.965569,"median":-0.844549,"eighty":-0.565353,"marketCap":16045436},{"date":"2022-03-25","current":-0.801515,"twenty":-2.965569,"median":-0.837017,"eighty":-0.565353,"marketCap":21333136},{"date":"2022-04-01","current":-0.712458,"twenty":-2.932891,"median":-0.829295,"eighty":-0.573855,"marketCap":18962788},{"date":"2022-04-08","current":-0.650735,"twenty":-2.883873,"median":-0.816854,"eighty":-0.582356,"marketCap":17319954},{"date":"2022-04-14","current":-0.637102,"twenty":-2.870802,"median":-0.811898,"eighty":-0.585757,"marketCap":16957108},{"date":"2022-04-22","current":-0.615317,"twenty":-2.854463,"median":-0.806889,"eighty":-0.593409,"marketCap":16377284},{"date":"2022-04-29","current":-0.534344,"twenty":-2.831588,"median":-0.794895,"eighty":-0.573762,"marketCap":14222091},{"date":"2022-05-06","current":-0.422789,"twenty":-2.464052,"median":-0.788264,"eighty":-0.559402,"marketCap":11252961},{"date":"2022-05-13","current":-0.412841,"twenty":-2.329465,"median":-0.786902,"eighty":-0.547771,"marketCap":11060415},{"date":"2022-05-20","current":-0.424683,"twenty":-2.235505,"median":-0.786393,"eighty":-0.513494,"marketCap":11377678},{"date":"2022-05-27","current":-0.418149,"twenty":-2.200118,"median":-0.76512,"eighty":-0.503186,"marketCap":11202636},{"date":"2022-06-03","current":-0.444937,"twenty":-2.152528,"median":-0.762397,"eighty":-0.476087,"marketCap":11920305},{"date":"2022-06-10","current":-0.438567,"twenty":-2.123242,"median":-0.758562,"eighty":-0.466914,"marketCap":11749640},{"date":"2022-06-17","current":-0.367514,"twenty":-2.11226,"median":-0.754228,"eighty":-0.451634,"marketCap":9846067},{"date":"2022-06-24","current":-0.366126,"twenty":-2.102498,"median":-0.751505,"eighty":-0.445495,"marketCap":9808871},{"date":"2022-07-01","current":-0.325781,"twenty":-2.089075,"median":-0.746385,"eighty":-0.44007,"marketCap":8727991},{"date":"2022-07-08","current":-0.400264,"twenty":-2.071991,"median":-0.743612,"eighty":-0.43499,"marketCap":10723461},{"date":"2022-07-15","current":-0.383848,"twenty":-2.061009,"median":-0.737891,"eighty":-0.428094,"marketCap":10283670},{"date":"2022-07-22","current":-0.363839,"twenty":-2.043925,"median":-0.728361,"eighty":-0.424683,"marketCap":9747606},{"date":"2022-07-29","current":-0.315572,"twenty":-1.981692,"median":-0.721554,"eighty":-0.420835,"marketCap":8454489},{"date":"2022-08-05","current":-0.423458,"twenty":-1.901155,"median":-0.712458,"eighty":-0.418084,"marketCap":11344857},{"date":"2022-08-12","current":-0.570101,"twenty":-1.792553,"median":-0.709879,"eighty":-0.416508,"marketCap":15273575},{"date":"2022-08-19","current":4.414871,"twenty":-1.766928,"median":-0.701936,"eighty":-0.411475,"marketCap":11527227},{"date":"2022-08-26","current":4.512979,"twenty":-1.683951,"median":-0.68888,"eighty":-0.405749,"marketCap":11783387},{"date":"2022-09-02","current":4.029939,"twenty":-1.682731,"median":-0.683343,"eighty":-0.400558,"marketCap":10522170},{"date":"2022-09-09","current":4.038124,"twenty":-1.677849,"median":-0.676931,"eighty":-0.398303,"marketCap":10543542},{"date":"2022-09-16","current":3.819847,"twenty":-1.671748,"median":-0.667097,"eighty":-0.394592,"marketCap":9973621},{"date":"2022-09-23","current":3.113175,"twenty":-1.671748,"median":-0.660291,"eighty":-0.391921,"marketCap":8128501},{"date":"2022-09-30","current":2.701177,"twenty":-1.659545,"median":-0.650735,"eighty":-0.39079,"marketCap":7052774},{"date":"2022-10-07","current":2.709363,"twenty":-1.647343,"median":-0.642122,"eighty":-0.38563,"marketCap":7074146},{"date":"2022-10-14","current":2.589311,"twenty":-1.604634,"median":-0.637102,"eighty":-0.373068,"marketCap":6760690},{"date":"2022-10-21","current":2.837601,"twenty":-1.58633,"median":-0.630286,"eighty":-0.367514,"marketCap":7408975},{"date":"2022-10-28","current":2.589311,"twenty":-1.568026,"median":-0.61381,"eighty":-0.365524,"marketCap":6760690},{"date":"2022-11-04","current":2.335563,"twenty":-1.549723,"median":-0.605735,"eighty":-0.361316,"marketCap":6098156},{"date":"2022-11-11","current":2.23461,"twenty":-1.53752,"median":-0.602301,"eighty":-0.35118,"marketCap":5834568},{"date":"2022-11-18","current":-0.398957,"twenty":-1.507014,"median":-0.597644,"eighty":-0.35538,"marketCap":3776927},{"date":"2022-11-25","current":-0.610649,"twenty":-1.492371,"median":-0.60083,"eighty":-0.357408,"marketCap":5781011},{"date":"2022-12-02","current":-0.69044,"twenty":-1.212508,"median":-0.602849,"eighty":-0.359061,"marketCap":6536396},{"date":"2022-12-09","current":-0.498289,"twenty":-1.136657,"median":-0.60083,"eighty":-0.35977,"marketCap":4717305},{"date":"2022-12-16","current":-0.381045,"twenty":-1.083947,"median":-0.59593,"eighty":-0.361028,"marketCap":3607351},{"date":"2022-12-23","current":-0.311024,"twenty":-1.067795,"median":-0.594423,"eighty":-0.354976,"marketCap":2944461},{"date":"2022-12-30","current":-0.846766,"twenty":-1.054193,"median":-0.590172,"eighty":-0.352489,"marketCap":8016335},{"date":"2023-01-06","current":-0.785441,"twenty":-1.058443,"median":-0.595109,"eighty":-0.354169,"marketCap":7435768},{"date":"2023-01-13","current":-1.118311,"twenty":-1.058443,"median":-0.597622,"eighty":-0.356394,"marketCap":10587051},{"date":"2023-01-20","current":-0.996847,"twenty":-1.067829,"median":-0.602301,"eighty":-0.358201,"marketCap":9437147},{"date":"2023-01-27","current":-0.938209,"twenty":-1.066328,"median":-0.605735,"eighty":-0.359453,"marketCap":8882021},{"date":"2023-02-03","current":-1.143442,"twenty":-1.078731,"median":-0.610649,"eighty":-0.360164,"marketCap":10824963},{"date":"2023-02-10","current":-0.967528,"twenty":-1.070566,"median":-0.618682,"eighty":-0.361739,"marketCap":9159584},{"date":"2023-02-17","current":-0.967528,"twenty":-1.067829,"median":-0.630252,"eighty":-0.363512,"marketCap":9159584},{"date":"2023-02-24","current":-0.904701,"twenty":-1.066945,"median":-0.631818,"eighty":-0.363839,"marketCap":8564806},{"date":"2023-03-03","current":-0.900513,"twenty":-1.063862,"median":-0.637102,"eighty":-0.363839,"marketCap":8525154},{"date":"2023-03-10","current":-0.846063,"twenty":-1.045691,"median":-0.641867,"eighty":-0.365524,"marketCap":8009679},{"date":"2023-03-17","current":-0.795802,"twenty":-1.030354,"median":-0.647255,"eighty":-0.365881,"marketCap":7533857},{"date":"2023-03-24","current":-0.517989,"twenty":-1.005224,"median":-0.646473,"eighty":-0.365962,"marketCap":7386522},{"date":"2023-03-31","current":-1.111781,"twenty":-1.005224,"median":-0.644425,"eighty":-0.366126,"marketCap":15853999},{"date":"2023-04-06","current":-0.688546,"twenty":-1.01025,"median":-0.647255,"eighty":-0.367236,"marketCap":9818669},{"date":"2023-04-14","current":-0.713644,"twenty":-1.001873,"median":-0.652987,"eighty":-0.368102,"marketCap":10176564},{"date":"2023-04-21","current":-0.654174,"twenty":-1.001035,"median":-0.65541,"eighty":-0.369295,"marketCap":9328517},{"date":"2023-04-28","current":-0.737945,"twenty":-1.001035,"median":-0.654615,"eighty":-0.371189,"marketCap":10523092},{"date":"2023-05-05","current":-0.628469,"twenty":-0.997685,"median":-0.65541,"eighty":-0.372642,"marketCap":8961974},{"date":"2023-05-12","current":-0.656852,"twenty":-0.995114,"median":-0.654615,"eighty":-0.373035,"marketCap":9366708},{"date":"2023-05-19","current":-0.732361,"twenty":-0.993063,"median":-0.656852,"eighty":-0.374309,"marketCap":9077612},{"date":"2023-05-25","current":-0.676384,"twenty":-0.991322,"median":-0.659918,"eighty":-0.377706,"marketCap":8383782},{"date":"2023-06-02","current":-0.778028,"twenty":-0.988731,"median":-0.663013,"eighty":-0.380276,"marketCap":9643654},{"date":"2023-06-09","current":-0.869878,"twenty":-0.98448,"median":-0.667097,"eighty":-0.382166,"marketCap":10782141},{"date":"2023-06-15","current":-0.875281,"twenty":-0.981929,"median":-0.67307,"eighty":-0.384204,"marketCap":10849110},{"date":"2023-06-23","current":-0.923908,"twenty":-0.981929,"median":-0.674471,"eighty":-0.385274,"marketCap":11451839},{"date":"2023-06-30","current":-0.864475,"twenty":-0.980827,"median":-0.677186,"eighty":-0.386075,"marketCap":10715171},{"date":"2023-07-07","current":-0.950923,"twenty":-0.97876,"median":-0.681631,"eighty":-0.386553,"marketCap":11786688},{"date":"2023-07-14","current":-1.102206,"twenty":-0.981929,"median":-0.685714,"eighty":-0.387278,"marketCap":13661843},{"date":"2023-07-21","current":-1.085997,"twenty":-0.98788,"median":-0.687352,"eighty":-0.387446,"marketCap":13460933},{"date":"2023-07-28","current":-1.167042,"twenty":-0.998522,"median":-0.69044,"eighty":-0.387685,"marketCap":14465481},{"date":"2023-08-04","current":-1.123818,"twenty":-1.015276,"median":-0.695051,"eighty":-0.389582,"marketCap":13929722},{"date":"2023-08-11","current":-0.372805,"twenty":-1.046685,"median":-0.69506,"eighty":-0.389582,"marketCap":4620917},{"date":"2023-08-18","current":-0.316168,"twenty":-1.036489,"median":-0.691021,"eighty":-0.386075,"marketCap":4250561},{"date":"2023-08-25","current":-0.316168,"twenty":-1.015276,"median":-0.688546,"eighty":-0.377706,"marketCap":4250561},{"date":"2023-09-01","current":-0.347683,"twenty":-1.002711,"median":-0.685385,"eighty":-0.372322,"marketCap":4674246},{"date":"2023-09-08","current":-0.397658,"twenty":-1.001035,"median":-0.683343,"eighty":-0.370372,"marketCap":5346109},{"date":"2023-09-15","current":-0.424944,"twenty":-1.001035,"median":-0.677186,"eighty":-0.371839,"marketCap":5712941},{"date":"2023-09-19","current":-0.414479,"twenty":-1.001035,"median":-0.676384,"eighty":-0.37208,"marketCap":5572256},{"date":"2023-09-29","current":-0.368654,"twenty":-1.001035,"median":-0.674471,"eighty":-0.368654,"marketCap":4956181},{"date":"2023-10-06","current":-0.39054,"twenty":-0.996847,"median":-0.66982,"eighty":-0.369556,"marketCap":5250426},{"date":"2023-10-13","current":-0.378092,"twenty":-0.995114,"median":-0.666828,"eighty":-0.371189,"marketCap":5083074},{"date":"2023-10-17","current":-0.411059,"twenty":-0.994276,"median":-0.664374,"eighty":-0.371839,"marketCap":5526280},{"date":"2023-11-02","current":-0.376177,"twenty":-0.993063,"median":-0.66128,"eighty":-0.372563,"marketCap":5057328},{"date":"2023-11-10","current":-0.355659,"twenty":-0.990876,"median":-0.656852,"eighty":-0.371023,"marketCap":4781473},{"date":"2023-11-17","current":-0.36942,"twenty":-0.98703,"median":-0.65541,"eighty":-0.369529,"marketCap":4820558},{"date":"2023-11-24","current":-0.413213,"twenty":-0.98448,"median":-0.654174,"eighty":-0.370164,"marketCap":5392020},{"date":"2023-12-01","current":-0.441467,"twenty":-0.981929,"median":-0.652797,"eighty":-0.371138,"marketCap":5760705},{"date":"2023-12-08","current":-0.431578,"twenty":-0.981562,"median":-0.649739,"eighty":-0.371431,"marketCap":5631665},{"date":"2023-12-15","current":-0.416816,"twenty":-0.97876,"median":-0.646473,"eighty":-0.371839,"marketCap":5439027},{"date":"2023-12-22","current":-0.420347,"twenty":-0.973249,"median":-0.644586,"eighty":-0.372825,"marketCap":5485113},{"date":"2023-12-29","current":-0.461881,"twenty":-0.972713,"median":-0.642377,"eighty":-0.372883,"marketCap":6027080},{"date":"2024-01-05","current":-0.385997,"twenty":-0.972207,"median":-0.641518,"eighty":-0.372969,"marketCap":5036876},{"date":"2024-01-12","current":-0.376548,"twenty":-0.970041,"median":-0.637102,"eighty":-0.373217,"marketCap":4913573},{"date":"2024-01-19","current":-0.376548,"twenty":-0.967528,"median":-0.633446,"eighty":-0.373143,"marketCap":4913573},{"date":"2024-01-26","current":-0.363049,"twenty":-0.96669,"median":-0.630286,"eighty":-0.372825,"marketCap":4737426},{"date":"2024-02-02","current":-0.416981,"twenty":-0.962806,"median":-0.628469,"eighty":-0.372825,"marketCap":5441185},{"date":"2024-02-09","current":-0.319738,"twenty":-0.96037,"median":-0.623231,"eighty":-0.371427,"marketCap":4172255},{"date":"2024-02-16","current":-0.314051,"twenty":-0.957505,"median":-0.61381,"eighty":-0.369425,"marketCap":4098049},{"date":"2024-02-23","current":-0.300332,"twenty":-0.950923,"median":-0.60922,"eighty":-0.368249,"marketCap":3919026},{"date":"2024-03-01","current":-0.285759,"twenty":-0.94552,"median":-0.603229,"eighty":-0.365962,"marketCap":3728872},{"date":"2024-03-08","current":-0.278224,"twenty":-0.942397,"median":-0.599359,"eighty":-0.363839,"marketCap":3630548},{"date":"2024-03-15","current":-0.261235,"twenty":-0.940117,"median":-0.595519,"eighty":-0.363404,"marketCap":3408857},{"date":"2024-03-22","current":-0.277087,"twenty":-0.938209,"median":-0.593738,"eighty":-0.36253,"marketCap":3615707},{"date":"2024-03-28","current":-0.410438,"twenty":-0.938209,"median":-0.582356,"eighty":-0.361028,"marketCap":5048382},{"date":"2024-04-05","current":-0.398186,"twenty":-0.938209,"median":-0.571746,"eighty":-0.361914,"marketCap":4897684},{"date":"2024-04-12","current":-0.303182,"twenty":-0.931507,"median":-0.565353,"eighty":-0.361028,"marketCap":3729136},{"date":"2024-04-19","current":-0.350943,"twenty":-0.929832,"median":-0.559354,"eighty":-0.359061,"marketCap":4316603},{"date":"2024-04-26","current":-0.431238,"twenty":-0.929832,"median":-0.552601,"eighty":-0.357464,"marketCap":5304228},{"date":"2024-05-03","current":-0.504611,"twenty":-0.929832,"median":-0.549758,"eighty":-0.359061,"marketCap":6206713},{"date":"2024-05-10","current":-0.480384,"twenty":-0.929415,"median":-0.546835,"eighty":-0.35977,"marketCap":5908722},{"date":"2024-05-17","current":-0.407804,"twenty":-0.929311,"median":-0.543164,"eighty":-0.361028,"marketCap":5500050},{"date":"2024-05-24","current":-0.358259,"twenty":-0.924989,"median":-0.534344,"eighty":-0.35977,"marketCap":4831834},{"date":"2024-05-31","current":-0.320072,"twenty":-0.923908,"median":-0.527464,"eighty":-0.358121,"marketCap":4316813},{"date":"2024-06-07","current":-0.325627,"twenty":-0.918102,"median":-0.520417,"eighty":-0.352702,"marketCap":4391725},{"date":"2024-06-14","current":-0.315212,"twenty":-0.913389,"median":-0.514587,"eighty":-0.349811,"marketCap":4251265},{"date":"2024-06-21","current":-0.330487,"twenty":-0.911478,"median":-0.507968,"eighty":-0.342356,"marketCap":4457273},{"date":"2024-06-28","current":-0.317295,"twenty":-0.910184,"median":-0.505842,"eighty":-0.339575,"marketCap":4279357},{"date":"2024-07-05","current":-0.30202,"twenty":-0.907214,"median":-0.504098,"eighty":-0.335275,"marketCap":4073348},{"date":"2024-07-12","current":-0.31174,"twenty":-0.904701,"median":-0.501591,"eighty":-0.330597,"marketCap":4204444},{"date":"2024-07-15","current":-0.315212,"twenty":-0.904701,"median":-0.49994,"eighty":-0.330487,"marketCap":4251265},{"date":"2024-08-02","current":-0.253419,"twenty":-0.904701,"median":-0.498289,"eighty":-0.329742,"marketCap":3417867},{"date":"2024-08-09","current":-0.252725,"twenty":-0.902443,"median":-0.487711,"eighty":-0.32575,"marketCap":3408503},{"date":"2024-08-16","current":-0.310036,"twenty":-0.900786,"median":-0.476087,"eighty":-0.322579,"marketCap":4394446},{"date":"2024-08-23","current":-0.300008,"twenty":-0.900513,"median":-0.47231,"eighty":-0.321132,"marketCap":4252308},{"date":"2024-08-30","current":-0.300843,"twenty":-0.897617,"median":-0.467585,"eighty":-0.319624,"marketCap":4264153},{"date":"2024-09-06","current":-0.306693,"twenty":-0.894355,"median":-0.465907,"eighty":-0.318303,"marketCap":4347067},{"date":"2024-09-13","current":-0.311707,"twenty":-0.892632,"median":-0.462608,"eighty":-0.317049,"marketCap":4418136},{"date":"2024-09-20","current":-0.320064,"twenty":-0.892326,"median":-0.459208,"eighty":-0.317065,"marketCap":4536585},{"date":"2024-09-27","current":-0.281623,"twenty":-0.890568,"median":-0.455058,"eighty":-0.316168,"marketCap":3991721},{"date":"2024-10-04","current":-0.297501,"twenty":-0.888577,"median":-0.448457,"eighty":-0.315212,"marketCap":4216773},{"date":"2024-10-11","current":-0.290815,"twenty":-0.887947,"median":-0.444099,"eighty":-0.313361,"marketCap":4122014},{"date":"2024-10-18","current":-0.298336,"twenty":-0.885675,"median":-0.442122,"eighty":-0.312157,"marketCap":4228618},{"date":"2024-10-25","current":-0.289144,"twenty":-0.881819,"median":-0.442081,"eighty":-0.31174,"marketCap":4098325},{"date":"2024-10-31","current":-0.259059,"twenty":-0.880257,"median":-0.44122,"eighty":-0.311068,"marketCap":3671909},{"date":"2024-11-08","current":-0.212262,"twenty":-0.878267,"median":-0.439544,"eighty":-0.310352,"marketCap":3008596},{"date":"2024-11-15","current":-0.220644,"twenty":-0.87312,"median":-0.438648,"eighty":-0.309383,"marketCap":3103355},{"date":"2024-11-22","current":-0.230645,"twenty":-0.869878,"median":-0.434565,"eighty":-0.307597,"marketCap":3244019},{"date":"2024-11-29","current":-0.232535,"twenty":-0.868865,"median":-0.433153,"eighty":-0.30673,"marketCap":3270609},{"date":"2024-12-06","current":-0.165421,"twenty":-0.864746,"median":-0.431408,"eighty":-0.304339,"marketCap":2326653},{"date":"2024-12-13","current":-0.223083,"twenty":-0.864475,"median":-0.429318,"eighty":-0.30202,"marketCap":3137657},{"date":"2024-12-20","current":-0.170148,"twenty":-0.864475,"median":-0.427619,"eighty":-0.300848,"marketCap":2393128},{"date":"2024-12-27","current":-0.167312,"twenty":-0.864475,"median":-0.427376,"eighty":-0.300008,"marketCap":2353243},{"date":"2025-01-03","current":-0.175819,"twenty":-0.862276,"median":-0.425615,"eighty":-0.298713,"marketCap":2472899},{"date":"2025-01-10","current":-0.189998,"twenty":-0.858019,"median":-0.424813,"eighty":-0.297501,"marketCap":2672327},{"date":"2025-01-17","current":-0.156914,"twenty":-0.853695,"median":-0.424683,"eighty":-0.296397,"marketCap":2206996},{"date":"2025-01-24","current":-0.139899,"twenty":-0.851577,"median":-0.423458,"eighty":-0.29497,"marketCap":1967683},{"date":"2025-01-31","current":-0.281219,"twenty":-0.850213,"median":-0.422628,"eighty":-0.294391,"marketCap":3955351},{"date":"2025-02-07","current":-0.255654,"twenty":-0.850155,"median":-0.421689,"eighty":-0.291697,"marketCap":3595774},{"date":"2025-02-14","current":-0.202557,"twenty":-0.849841,"median":-0.420673,"eighty":-0.288648,"marketCap":2848959},{"date":"2025-02-21","current":-0.192724,"twenty":-0.849371,"median":-0.420347,"eighty":-0.287568,"marketCap":2710660},{"date":"2025-02-28","current":-0.162045,"twenty":-0.849371,"median":-0.418149,"eighty":-0.286746,"marketCap":2279167},{"date":"2025-03-07","current":-0.164602,"twenty":-0.849371,"median":-0.417423,"eighty":-0.2853,"marketCap":2315125},{"date":"2025-03-14","current":-0.180433,"twenty":-0.84915,"median":-0.416981,"eighty":-0.283159,"marketCap":2537786},{"date":"2025-03-21","current":-0.154081,"twenty":-0.847966,"median":-0.416696,"eighty":-0.281643,"marketCap":2167145},{"date":"2025-03-28","current":-0.209966,"twenty":-0.846669,"median":-0.415332,"eighty":-0.281219,"marketCap":3031487},{"date":"2025-04-04","current":-0.19611,"twenty":-0.846239,"median":-0.413798,"eighty":-0.278423,"marketCap":2831440},{"date":"2025-04-11","current":-0.207073,"twenty":-0.846031,"median":-0.412841,"eighty":-0.273332,"marketCap":2989719},{"date":"2025-04-17","current":-0.213255,"twenty":-0.845904,"median":-0.412325,"eighty":-0.26877,"marketCap":3078975},{"date":"2025-04-25","current":-0.223974,"twenty":-0.843194,"median":-0.411077,"eighty":-0.265745,"marketCap":3233733}],"updateTime":1745749334637}}}